Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Research Infectious Disease Laboratory (RIDL) is a specialized contract research organization and CLIA-certified diagnostic facility that provides comprehensive testing and research services for infectious diseases. The laboratory offers a wide range of services including viral load testing, serological assays, and molecular diagnostics to support clinical trials and public health initiatives. RIDL is particularly recognized for its expertise in emerging pathogens and has played a significant role in diagnostic development and surveillance for viruses such as SARS-CoV-2, Zika, and West Nile. By bridging the gap between academic research and clinical application, the lab serves as a critical partner for biotechnology and pharmaceutical companies seeking validated testing solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Research Infectious Diseases Labs.